Opinion
Video
ASCO 2024 and Beyond: Addressing NSCLC Unmet Needs and Future Research Directions
Author(s):
Jason Porter, MD, provides concluding insights on the LAURA phase 3 trial, CHRYSALIS-2 study, TROPION-Lung05 trial, and CheckMate 9LA study, along with other notable findings from the ASCO 2024 conference.
Video content above is prompted by the following questions:
- How do these four trials address the unmet needs of patients with NSCLC?
- After the presentation of advancements in NSCLC research at ASCO, how do you envision the future of personalized medicine in this disease?
- Please discuss any other data in NSCLC released at ASCO 2024 that you find noteworthy to share with colleagues.
- Outside of ASCO 2024, what ongoing research efforts are you most excited for in the treatment and management of NSCLC? What can we look forward to through the end of the year and beyond?
Related Videos
Related Content
